OTC : CZMWY

Carl Zeiss Meditec AG

$31.69 USD

-$0.99 (-3.03%)

Volume
720
Average Volume
4.12K
Market Capitalization
$2.77B
P/E Ratio
20.43
Dividend Yield
1.98%
Price Target
Year High
$60.37
Year Low
$26.65
Day High
—
Day Low
—
Payout Ratio
$0.54
Current Ratio
$2.43
Company Overview

OTC

Andreas Pecher

Medical - Instruments & Supplies

Healthcare

CZMWY

5798

DE

USD

https://www.zeiss.de/meditec-ag/home.html

49 3641 2200

14218T105

N/A

Liquidity Metrics

0.29

2.43

1.37

0.05

0.54

Sales & Valuation

$2.23B

0.92

1.16

6.57

4.23

Profitability

$1.52

$141.21M

3.41%

4.68%

4.27%

2.69%

P/E Metrics

20.43

-0.87

-0.87

Analyst Price Target & Rating

Neutral

3/5

4 Analysts

%

Financial Health Scores

3.17

6/9

$725.33M

$3.34B

$1.23B

$226.56M

Key Metrics (TTM)

$3.11B

1.18

10.25

2.43

4.27%

4.08%

3.57%

14.71%

$23.54

206 days

Company Executives
Name Title
Christian Munster Head of Global Regulatory & Clinical Affairs, CoCe Site Jena & Emp. Rep. Member of Supervisory Board
Euan S. Thomson President of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Business Unit
Magnus Reibenspiess Head of the Microsurgery Strategic Business Unit - ZEISS Medical Technology
Stefanie Spanagel Chief Operating Officer
Andreas Pecher Interim Chairman of the Management Board & Interim CEO
Andrew Chang Head of Sales for Ophthalmic Devices & President of Carl Zeiss Meditec, Inc.
Justus Felix Wehmer Chief Financial Officer & Member of the Management Board
Sebastian Frericks Director of Investor Relations
Steven C. Schallhorn Chief Medical Officer for Global Ophthalmic Devices
Eva-Maria Heine Chief Human Resources Officer
Poll Results

No votes yet today — be the first to share your view!

About Carl Zeiss Meditec AG (OTC:CZMWY) Stock

Carl Zeiss Meditec AG functions as a prominent global medical technology firm, conducting its operations across Germany, other European nations, the United States, and various Asian markets. Its business is organized into two principal divisions: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment provides an array of products and solutions tailored for the diagnosis and therapeutic management of ocular conditions, including specialized systems and essential consumables for cataract, retinal, and refractive surgical procedures. This division serves ophthalmologists, optometrists, and medical and surgical professionals in hospitals and ambulatory surgery centers. The Microsurgery segment focuses on delivering advanced visualization tools vital for intricate surgical interven ... tions, additionally supplying specialized solutions for ear, nose, and throat (ENT), plastic and reconstructive, dental, and spinal surgeries. This segment supports a diverse group of medical practitioners across various disciplines, as well as healthcare institutions. Established in 1846 and headquartered in Jena, Germany, the company operates as a subsidiary of Carl Zeiss AG.

Carl Zeiss Meditec AG (CZMWY) Q2 2026 Earnings Call Transcript

2026-05-13 22:40:44

Carl Zeiss Meditec AG (CZMWY) Q2 2026 Earnings Call Transcript

Carl Zeiss Meditec Q2 Earnings Call Highlights

2026-05-12 06:10:17

Carl Zeiss Meditec ETR: AFX reported weaker first-half results for fiscal 2025/2026 and outlined a broad restructuring plan aimed at restoring profitability over the next three years, as management pointed to currency headwinds, soft equipment demand and pressure in China's intraocular lens business.

Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Sees Large Increase in Short Interest

2026-04-27 02:20:56

Carl Zeiss Meditec AG (OTCMKTS:CZMWY - Get Free Report) was the recipient of a large growth in short interest in April. As of April 15th, there was short interest totaling 5,102 shares, a growth of 89.7% from the March 31st total of 2,690 shares. Based on an average daily volume of 8,140 shares, the short-interest

Carl Zeiss Meditec: Bad Optics But With 'Buy' Potential

2026-04-21 17:42:02

Carl Zeiss Meditec AG is rated a "Buy" despite recent operational weakness and geopolitical headwinds, especially in Asia-Pacific and North America. Sales declined 4.8% in Q1, with margin compression and a suspended 2025/2026 outlook due to weak demand across Asia-Pacific and North America. CZMWF now trades at a significant discount to peers, with a 2026 price target of $39.26, implying ~20% upside against a discounted multiple.

Frequently Asked Questions

What is the current Carl Zeiss Meditec AG (CZMWY) stock price?

Carl Zeiss Meditec AG(OTC:CZMWY) stock price is $31.69 in the last trading session. During the trading session, CZMWY stock reached the peak price of $60.37 while $26.65 was the lowest point it dropped to. The percentage change in CZMWY stock occurred in the recent session was --3.03% while the dollar amount for the price change in CZMWY stock was -$0.99.

CZMWY's industry and sector of operation?

The OTC listed CZMWY is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector.

Who are the executives of CZMWY?

Christian Munster | Head of Global Regulatory & Clinical Affairs, CoCe Site Jena & Emp. Rep. Member of Supervisory Board
Euan S. Thomson | President of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Business Unit
Magnus Reibenspiess | Head of the Microsurgery Strategic Business Unit - ZEISS Medical Technology
Stefanie Spanagel | Chief Operating Officer
Andreas Pecher | Interim Chairman of the Management Board & Interim CEO

How many employees does CZMWY have?

Number of CZMWY employees currently stands at 5798. CZMWY operates from Goschwitzer Strasse 51-52, Jena, TH 07745, DE.

Link for CZMWY official website?

Official Website of CZMWY is: https://www.zeiss.de/meditec-ag/home.html

How do I contact CZMWY?

CZMWY could be contacted at phone #49 3641 2200 and can also be accessed through its website. CZMWY operates from Goschwitzer Strasse 51-52, Jena, TH 07745, DE.

How many shares of CZMWY are traded daily?

The average number of CZMWY shares traded daily for last 3 months was 4.12K.

What is the market cap of CZMWY currently?

The market value of CZMWY currently stands at $2.77B with its latest stock price at $31.69